Finance

Lists
9989:HKG
Shenzhen Hepalink Pharmaceutical Group Ord Shs H
HK$4.20
-0.59%
(-0.025) 1D
Sep 7, 3:16:43 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 9989...
Open
HK$4.21
High
HK$4.24
Low
HK$4.20
Mkt. cap
15.15B
Avg. vol.
0.00
Volume
233.50K
Dividend
3.95%
Quarterly dividend
HK$0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
26.06
52-wk high
HK$6.11
52-wk low
HK$3.74
EPS
HK$0.16
Shares outstanding
220.09M
No. of employees
2K
Open
HK$4.21
High
HK$4.24
Low
HK$4.20
Mkt. cap
15.15B
Avg. vol.
0.00
Volume
233.50K
Dividend
3.95%
Quarterly dividend
HK$0.04
Ex-dividend date
Jun 18, 2026
P/E ratio
26.06
52-wk high
HK$6.11
52-wk low
HK$3.74
EPS
HK$0.16
Shares outstanding
220.09M
No. of employees
2K
About Shenzhen Hepalink Pharmaceutical Group Ord Shs H
CEO-
Employees2.1K
FoundedApr 21, 1998
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.38B
1.28B
1.33B
1.25B
Cost of goods sold
884.21M
900.40M
876.31M
821.09M
Cost of revenue
884.21M
900.40M
876.31M
821.09M
Research and development expenses
73.11M
50.33M
36.44M
45.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
216.50M
252.73M
209.31M
238.09M
Operating expense
291.36M
336.08M
263.62M
278.00M
Total operating expenses
1.18B
1.24B
1.14B
1.10B
Operating income
201.54M
48.03M
190.92M
149.59M
Other non operating income
182.67M
-254.18M
-122.99M
-59.81M
EBT including unusual items
157.96M
-239.36M
207.68M
72.85M
EBT excluding unusual items
188.04M
-97.72M
93.38M
86.22M
Income tax expense
26.52M
-29.37M
20.31M
-14.68M
Effective tax rate
16.79%
12.27%
9.78%
-20.15%
Other operating expenses
6.60M
16.33M
8.11M
3.78M
Net income
131.73M
-204.09M
187.57M
87.71M
Net profit margin
9.57%
-15.89%
14.09%
7.02%
Earnings per share
-
-
-
-
Interest and investment income
33.52M
-
38.50M
13.05M
Interest expense
-15.15M
-32.17M
-13.05M
-16.62M
Net interest expenses
18.37M
-32.17M
25.45M
-3.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
271.82M
128.19M
271.08M
233.46M
Gain or loss from assets sale
1.29M
-1.84M
-
26.67K
AI content may include mistakes. Learn more
Google apps